CGTN
8.3.2021 20:08:11 CET | Business Wire | Press release
China is mulling improving the electoral system of the Hong Kong Special Administrative Region (HKSAR) – but critics say it's a plan to eliminate opposition forces in the city.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210308005793/en/
Why are improvements imperative?
When explaining the draft decision on improving the electoral system of the HKSAR to lawmakers, Wang Chen, vice chairman of the National People's Congress (NPC) Standing Committee, said the move is to prevent anti-China, destabilizing forces from seizing power, citing the months-long riots in 2019.
"To remedy the situation, it is important to take necessary steps to improve the electoral system and remove existing institutional deficiencies and risks to ensure the administration of Hong Kong by Hong Kong people with patriots as the main body," Wang said.
Alex Fan, founding president of the International Youth Legal Exchange Federation in Hong Kong, told CGTN that "allowing non-patriots or even people endangering national security to participate in the election will put the 'One Country, Two Systems' in peril."
What can be improved?
According to the draft decision, the focus of the improvements will be on the reform and greater empowerment of the city's Election Committee.
"Hong Kong's chief executive will continue to be elected by the Election Committee. The committee will also elect a relatively large share of Legislative Council (LegCo) members and directly participate in the nomination of all LegCo candidates," Wang said, adding that the revisions to be made may be limited to Annex I and Annex II to the Basic Law, without revising the main body of the Basic Law.
How will it be carried out?
A two-step approach, namely, "decision plus amendment," has been put forward. The NPC, China's top legislature, first makes a decision on improving the electoral system of the HKSAR and authorizes its Standing Committee to amend. Then the NPC Standing Committee amends the Annex I and Annex II to the Basic Law of the HKSAR.
After the amendment at the state level is completed, the HKSAR will amend relevant local laws accordingly.
In consideration of the complexity of Hong Kong's election-related local laws, experts believe the process will take some time but will be completed before elections in Hong Kong in the second half of the year.
What would the improvements mean?
Li Huan, an associate research fellow at the Hong Kong and Macao Research Center, rejected concerns that the non-establishment camp in Hong Kong would have no room to participate in politics after the amendment, saying the decision "does not aim to serve the pro-establishment camp or to restrict the non-establishment camp."
"It depends on how one understands the non-establishment camp. People from the non-establishment camp are not necessarily unpatriotic or those who don't love Hong Kong," Li told CGTN.
This echoed the words of Xia Baolong, vice chairman of the National Committee of the Chinese People's Political Consultative Conference and head of the Hong Kong and Macao Affairs Office of the State Council, who has said the emphasis on "patriots governing Hong Kong" is not meant to erase all differences.
Liu Zhaojia, the vice chairman of the National Hong Kong and Macao Research Association, added: "Pro-establishment candidates can also rest easy. They must put in real efforts to solve Hong Kong's social and livelihood problems in order to gain a better political future."
The Liaison Office of the HKSAR voiced support for improving the electoral system, stating "it is the only way for Hong Kong society to end political disputes, refocus on development and protect the long-term prosperity and stability."
The HKSAR delegation to the Two Sessions said the proposed improvements would not make any change to "One Country, Two Systems," but would strengthen the principle, as well as put an end to the political chaos in Hong Kong and allow local society to focus on economic development, people's livelihood and the SAR's integration into the overall development of the country.
No one cares more about Hong Kong's democracy and continued prosperity and stability than the Central Government of China, Chinese State Councilor and Foreign Minister Wang Yi stated on Sunday, adding that Hong Kong's shift from chaos to stability serves the interests of all parties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005793/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
